Phase IV Study to Evaluate the Efficacy and Safety of Fang Le Shu Compared to Guo Na Fen for Controlled Ovarian Stimulation in Infertile Women Undergoing in Vitro Fertilization-embryo Transfer (IVF-ET).

PHASE4RecruitingINTERVENTIONAL
Enrollment

248

Participants

Timeline

Start Date

February 15, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

June 30, 2026

Conditions
Female Infertility
Interventions
DRUG

Fang Le Shu (Follitrope)

rFSH 150 IU, 225 IU, 300 IU per syringe

DRUG

Guo Na Fen (Gonal-F)

rFSH 450 IU per pen

Trial Locations (1)

Unknown

RECRUITING

The first affiliated hospital of Zhengzhou University, Zhengzhou

Sponsors

Lead Sponsor

All Listed Sponsors
lead

LG Chem

INDUSTRY

NCT06921395 - Phase IV Study to Evaluate the Efficacy and Safety of Fang Le Shu Compared to Guo Na Fen for Controlled Ovarian Stimulation in Infertile Women Undergoing in Vitro Fertilization-embryo Transfer (IVF-ET). | Biotech Hunter | Biotech Hunter